- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: KU-0059436 (AZD2281) (PARP inhibitor)
Total 679 results
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedSystemic Exposure to Sunscreen IngredientsUnited States
-
AstraZenecaCompletedOvarian NeoplasmsSpain, United States, Belgium, United Kingdom, Israel, Poland, Germany, Sweden, Australia
-
Affiliated Hospital of Jiangnan UniversityRecruitingCarcinoma, Non-Small-Cell Lung | EGF-R Positive Non-Small Cell Lung CancerChina
-
University of LeedsUniversity College London Hospitals; The Leeds Teaching Hospitals NHS Trust; University... and other collaboratorsRecruitingNon Small Cell Lung CancerUnited Kingdom
-
Shaare Zedek Medical CenterAstraZenecaRecruiting
-
AstraZenecaNo longer available
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Oslo University HospitalAstraZenecaActive, not recruitingLung Cancer | Targeted TherapySweden, Finland, Denmark, Lithuania, Norway
-
Soroka University Medical CenterActive, not recruiting
-
AstraZenecaRecruitingLiver CirrhosisDenmark, Spain, Germany, United States, France, Australia, China, Belgium, Netherlands, Switzerland, Austria, United Kingdom, Taiwan, Canada, Czechia
-
AstraZenecaTigerMedCompleted
-
Shandong Cancer Hospital and InstituteAstraZenecaUnknownNonsmall Cell Lung Cancer | Brain Metastases | EGFR-TKI Resistant Mutation | AZD9291
-
Hoffmann-La RocheCompleted
-
Massachusetts General HospitalActive, not recruitingEwing Sarcoma | RhabdomyosarcomaUnited States
-
University Hospital, CaenCompleted
-
MedSIRAstraZenecaCompletedNon-Small Cell Lung CancerSpain
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark
-
AstraZenecaCompletedAdvanced Prostate AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid NeoplasmUnited States
-
AstraZenecaTerminated
-
AstraZenecaCompletedTumorsNetherlands, Germany, United Kingdom
-
Sichuan UniversityNot yet recruitingLung Cancer | Extensive-stage Small-cell Lung CancerChina
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell CarcinomaUnited States
-
Sun Yat-sen UniversityNot yet recruitingOvarian Cancer | Primary Peritoneal Cancer | High Grade Serous Adenocarcinoma of Ovary | High Grade Endometrioid Ovarian Cancer | Fallopian-tube CancerChina
-
AstraZenecaCompletedNeoplasm MetastasisUnited Kingdom
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
AstraZenecaCompletedHealthy VolunteersUnited States
-
AstraZenecaCompletedHealthy VolunteersUnited Kingdom
-
Medical Research CouncilNational Health and Medical Research Council, Australia; AstraZeneca; Cancer... and other collaboratorsUnknownOvarian CancerUnited Kingdom
-
University College, LondonAstraZenecaWithdrawn
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
AstraZenecaCompletedCarcinoma | Head and Neck Neoplasms | Non-Small-Cell Lung CarcinomaUnited States, Spain
-
AstraZenecaCompletedAdvanced Solid MalignanciesChina
-
AstraZenecaCompleted
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
AstraZenecaCompletedAdvanced Solid Tumor | Liver MetastasesGermany
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
National Cancer Institute (NCI)Active, not recruitingSarcoma, Alveolar Soft PartUnited States
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
National Cancer Institute (NCI)CompletedFallopian Tube Cancer | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Epithelial Cancer | Stage I Ovarian Epithelial Cancer | Stage II Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma | Localized Malignant MesotheliomaUnited States
-
National Cancer Institute (NCI)CompletedAdult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain TumorUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Ovarian Carcinoma | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Recurrent Non-Small Cell... and other conditionsCanada
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
National Cancer Institute (NCI)CompletedIntraocular Melanoma | Recurrent Melanoma | Stage IV Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Extraocular Extension Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Superficial... and other conditionsCanada